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ABSTRACT Myocardial infarction is one of the most serious and widespread diseases in the world. In this work, 
a minimally invasive method for simulating myocardial infarction in mice is described in the Russian Federa-
tion for the very first time; the procedure is carried out by ligation of the coronary heart artery or by controlled 
electrocoagulation. As a part of the methodology, a series of anesthetic, microsurgical and revival protocols are 
designed, owing to which a decrease in the postoperational mortality from the initial 94.6 to 13.6% is achieved. 
ECG confirms the development of large-focal or surface myocardial infarction. Postmortal histological examina-
tion confirms the presence of necrosis foci in the heart muscles of 87.5% of animals. Altogether, the medical data 
allow us to conclude that an adequate mouse model for myocardial infarction was generated. A further study is 
focused on the standardization of the experimental procedure and the use of genetically modified mouse strains, 
with the purpose of finding the most efficient therapeutic approaches for this disease.
KEYWORDS myocardial infarction, coronary artery, ligation, controlled electrocoagulation, ECG (electrocardio-
gram).
INTRODUCTION
The simulation of myocardial infarction in animals is of 
great importance. First of all, there is a need to search 
for and develop optimal regimens for treating this dis-
ease using new approaches, including pharmacological 
and cell therapies.  As a result of the heterogeneity of 
the concept ‘myocardial infarction’ in humans and its 
various clinical manifestations (which may occur with 
another, already present pathology, i.e. diabetes mel-
litus or an increased concentration of cholesterol in the 
blood-stream), the question arises as to how to create 
an animal model which adequately reflects the com-
plex etiology of this disease. The general approach un-
derlying the selection of objects for biomodeling should 
satisfy the following criteria: 1) convenience in per-
forming  open-heart surgeries on animals; 2) the pos-
sibility  of using genetically modified or selectively bred 
animal strains with particular features of myocardial 
infarction simulated; and 3) the possibility of further 
standardization and certification  in compliance with   
international standards, for  both the technology and 
the laboratory in which the bio-model was obtained. 
It is reasonable to note that the first two conditions 
are in conflict with one another since the suitability of 
organisms for genetic studies is defined by their large 
population and small size (Drosophila melanogaster and 
Danio rerio are the classical genetic objects). This fact 
imposes an obvious restriction on carrying out surgical 
intervention. For to the third condition, it is necessary 
to obtain a quantity of model animals that will be suf-
ficient in terms of statistical reliability to successfully 
carry out the first stage of the preclinical testing of new 
pharmaceutical preparations, or for the performance of 
cell therapy.  From one perspective, the survival rate 
of animals is dependent upon the reliability of surgery 
and post-operation recovery protocols. In turn, this 
makes the process of bio-model development a larger 
scale one. On the other hand, the process depends on 
the availability of the certified facilities and hardware 
required for these procedures in the Russian Federa-
tion. Thus, a researcher has to compromise between 
the size of the animals and availability of their genetic 
strains, something that could affect the quality of pre-
clinical testing.
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In this work, laboratory mice were chosen for the 
simulation of myocardial infarction. Working with 
these animals is a well-established procedure at the 
internationally accredited Research and Production 
Division Nursery of Laboratory Animals branch of the 
Shemyakin and Ovchinnikov Institute of Bioorganic 
Chemistry. Thus, in the case of developing and certify-
ing the technology in accordance with the requirements 
of the International Organization for Standardization 
(ISO), there appears to be a possibility of not only us-
ing these bio-models in fundamental research, but also 
supplying Russian and foreign pharmaceutical com-
panies with them. The latter is particularly important, 
since preclinical testing should be carried out only on 
standard-model animals with a special health status 
(specific pathogen-free animals), which is maintained 
in the nursery at the branch of the Shemyakin and 
Ovchinnikov Institute of Bioorganic Chemistry. The 
main advantage provided by mice is that there is a de-
veloped network of their genetic resources, something 
that is in acute shortage in their relatives, rats.  The 
genetic diversity of inbred mouse strains allows us to 
select animals that are suitable for the study of car-
diovascular diseases. In particular, the A/J and C3H/
HeJ strains are resistant to atherosclerotic lesions of 
the aorta occurring when the animals are kept on an 
atherogenic diet (1.25% cholesterol, 0.5% cholic acid, 
and 15% fat), while the C57BL/6J mouse strains are 
extremely sensitive to the atherogenic diet, and the 
CBA/J strains are partially resistant [1–3]. There are 
also inbred rat strains which are potentially suitable 
for infarction simulation (in this context, spontaneously 
hypertensive rats (SHR) with an increased blood pres-
sure should be mentioned as a popular animal model) 
[4]. The main advantage of mouse models is the pos-
sibility of genetic manipulation of mouse embryonic 
stem cells, while this type of technology is still poorly 
developed for rat cells. Transgenesis, knock-out, and 
knock-in technologies, which are both tissue-specific 
and inducible, make it possible to remove and insert 
genes and sometimes to introduce point mutations into 
the mouse’s genome.
A researcher can always select the desired genes, 
their diversity enabling the creation of any genetic 
anomalies. These anomalies can act as a background 
for the infarction model. Thus, the microsurgical sim-
ulation of infarction can be applied to any available 
genetic model. For instance, if the infarction has to be 
simulated against a background of an increased cho-
lesterol level, mice carrying an apolipoprotein E4 gene 
(apoE4) should be chosen. Meanwhile, if the infarction 
has to be obtained against a background of cardiomy-
opathy, BALB/c or CD-1 mice should be used. The 
catalog of the Jackson Laboratory (USA) offers 373 
strains for cardiovascular disease research; twenty of 
them are selectively bred inbred strains, while the rest 
of the strains were obtained by genetic manipulations 
involving more than 50 genes. Among genetic models 
of diseases to which the microsurgical simulation of 
infarction can be applied, the following models can be 
mentioned: hypo- and hypertension, atherosclerosis, 
cardiomyopathy, lesion of coronary vessels, various 
metabolic syndromes, ischemia, hypo- and hyperc-
holesterolemia, and hypo- and hypertriglyceridemia. 
The combination of infarction simulated by means of 
microsurgical techniques with genetic models creates 
the prerequisites for reproducing various human heart 
diseases in mice and for further use of these animals 
in the clinical testing of drugs and in cell therapy. In 
the latter case, the observation of fluorescent-labeled 
(e.g., green fluorescent protein, GFP) or radioactively 
labeled (labeled with isotopes) cells injected into the 
heart (or vessels) is possible. The injected cell material 
is not rejected by homozygous animals, and the sites 
of its integration can be easily determined by multi-
slice computed tomography, thereby performing the 
intra-vital monitoring of the efficiency of cell therapy. 
The obvious shortcomings in the case of mice include 
the small size of their viscera and the small volume 
of blood circulation. The use of current methods for 
developing mouse bio-models leads to a high mortal-
ity of laboratory animals [5–9], a phenomena that is 
due to surgical aggression and loss of blood [10–13]. 
Therefore, a whole complex of anesthetic, microsur-
gical, and revival protocols is needed in order to per-
form a successful surgical intervention. This complex 
involves tracheal intubation for pulmonary ventilation 
by means of a medical ventilator, inhalation narcosis, 
bloodless thoracotomy, ligation of the left-anterior de-
scending coronary artery, procedures for the recovery 
of animals after surgical modification, and measure-
ment of electrocardiograms (ECG).The methodology 
and technical equipment in these procedures are con-
siderably different from those used in Russia for sur-
gical operations in rats.
The purpose of the present work is to develop for the 
first time in Russia a minimally invasive method for 
simulating myocardial infarction in laboratory mice. 
This will be accompanied by a complex of postoperation 
procedures aimed at achieving successful rehabilita-
tion of the animals operated upon, and monitoring their 
state during the postoperation period.
EXPERIMENTAL
Preoperation Period and Narcotization
In this work, we used 48 CD-1 mice of mixed sex, more 
than 8 weeks old, and weighing 3,2  36 g. Twenty-four RESEARCH ARTICLES
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hours prior to the operation, the mice were put into a 
cage with clean litter and water. Food was completely 
removed from the feedboxes. Just prior to the opera-
tion, the animals were weighed, and the needed vol-
ume of anesthetic was calculated. For the anesthesia, 
the injection mixed zoletil/xylazine narcosis (40–50 mg 
zoletil (tiletamine + zolazepam) per 1 kg of body weight 
and 15  –20 mg xylazine per 1 kg of body weight) was 
used. After surgical anesthesia and prior to tracheal 
intubation, the official drug, Vetranquil 1% inj. (Ceva 
Sante Animale, France), containing 1% acepromazine 
and 0.5% chlorobutanol, was used in a dose of 2–4 
mg/kg acepromazine and 1–2 mg/kg chlorobutanol 
for neuromuscular relaxation when needed. In order 
to prevent drying of the cornea, a moisture-donating 
gel, Normlgel – 0.9% (Mölnlycke Health Care), was ap-
plied to the eyes of the anesthetized animals prior to 
the surgery. The preparation of the surgical site on the 
left side of the chest was performed according to the 
following procedure:  the hair was shaved off, the skin 
was disinfected with a disinfectant, Decosept (BOR-
ER CHEMIE AG, Switzerland), and draped in a sterile 
transparent adhesive film, Opsite incise drape (Smith & 
Nephew, England) (Fig. 1a). Immediately after narcoti-
zation of the mice, ECG measurements were performed 
(the procedure is described below). In order to carry 
out the tracheal intubation, the mouse was fixed in a 
supine position on a heated surgical table. The tracheal 
intubation was carried out using an endotracheal tube 
with the following dimensions: the outer diameter was 
1–1.2 mm, the inner diameter was 0.6–0.8 mm, and the 
length was 25–30 mm) (Fig. 2b). The endotracheal tube 
was connected to a MiniVent Ventilator for Mice (HSE 
Harvard, Germany) (Fig. 1c), the inspiratory oxygen 
concentration was equal to 30% (oxygen was generated 
using a NewLife oxygen concentrator (AirSep, USA). 
The calculated values of the volume and the ventilation 
rate are listed in Table.
Surgical Procedure
Using a Leica MZ7.5 high-performance stereomicro-
scope (the magnification range is from 10x to 25x, 
the working distance is 25–30 cm), an incision in the 
fourth left intercostal space was made and the muscles 
of the chest wall (the broadest muscle of the back, the 
serratus ventralis muscle, and the external abdominal 
oblique muscle) were prized apart with scissors. Liga-
tures (surgical silk 3-0) were applied to these groups 
of muscles, and the muscles were moved in opposite 
directions. Using an eye dressing, forceps with angled 
serrated tips (Fine Science Tools, USA) and scissors, 
the intercostal muscle and parietal pleura were cut. 
Then, a Mini-Goldstein 3x3 (Fine Science Tools) re-
tractor was placed into the wound. Next, the pericar-
dium was cut by careful blunt dissection, and the lung 
was moved to the edge of the wound, giving access 
to the front (lower) surface of the heart (Fig. 1e). By 
manipulation with forceps and the pericardium in the 
incision wound, the heart was brought to a position 
suitable for finding the left coronary artery. This ar-
tery has a vivid red color and pulsates. With the help 
of an atraumatic needle and a nonabsorbable suture 
Prolene 6/0 (Ethicon, USA), the coronary artery was 
ligated in the center of its descending branch (Fig. 1f). 
If the ligation is performed correctly, the tachycardia, 
arrhythmia, and myocardial anemia develop fast in 
the ligated site. Then, the pericardium and the lung 
were moved back.
Since the identification of the coronary artery and 
its ligation are rather complicated procedures from a 
technical point of view, we proposed another method 
for the simulation of myocardial infarction. This meth-
od involves producing a necrotic zone by means of an 
electro-coagulator. In this method for simulating inf-
arction, an active electrode of the electro-coagulator 
acts directly on the myocardium after the front (lower) 
surface of the heart is reached.
After the surgical procedures were performed, the 
ribs and the pleura were sutured with two or three 
isolated, interrupted sutures using a VICRYL 5-0 
(Ethicon) thread, and the incision wound in the chest 
wall was closed. Then, the dissected muscles were put 
together and tightly pressed against each other. The 
wound was irrigated with a sterile saline solution. Af-
ter that, an uninterrupted glover’s suture was placed 
using an atraumatic needle and a nonabsorbable su-
ture VICRYL 4-0 (Ethicon). During this procedure, 
the chest in the area of the wound was compressed by 
forceps with the purpose of removing air and creat-
ing negative pressure in the thoracic cavity. In order 
to protect the surface of the surgical wound, the skin 
was treated with a special suspension of microporous 
aluminum AluSpray (Vetoquinol, France), which 
forms a thin layer of aluminum coating on the skin’s 
surface (Fig. 2).
Weight  
of a mouse,  
g
Stroke  
volume,  
µl
Ventilation rate, 
strokes/minute
22–27 175 130
28–35  200 120
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Temperature Conditions
In order to prevent the hypothermia that may result as 
a consequence of narcotization, the animal was placed 
on the heated surgical table with a heating tempera-
ture of 32–34°C. Immediately upon completion of the 
surgery, the animal was put into a recovery chamber 
Warm Air System (Vet Tech Solutions, England), sup-
plied with heated (30  –32°C) oxygen-enriched air.
Postoperation Period
Xylazine in a quantity of 10 mg xylozane per 1 kg of 
body weight was used for postoperation analgesia in 
the mice. When an animal emerged, it was put into an 
individual cage. Moist feed was given to the animal. 
Normally, there is no need for the removal of absorb-
able sutures.
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Fig. 1. Preopera-
tion and operation 
procedures during 
simulation of myo-
cardial infarction in 
mice: a – fixation 
of a mouse on a 
heated operation 
table; b – intuba-
tion of trachea; 
c – device for 
artificial pulmonary 
ventilation “MiniV-
ent Ventilator for 
Mice”; d – incision 
in the 4-th left inter-
costal space; e – 
front (lower) surface 
of the heart can be 
seen in the incision 
wound; f – ligation 
of the descending 
branch of the coro-
nary artery.RESEARCH ARTICLES
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ECG Measurements
ECG plays an important role in the diagnostics of myo-
cardial infarction. The changes observed in the ECG al-
low one to determine the infarction location, its extent 
and depth; i.e., whether it is large-focal, small-focal or 
intramural, sometimes the prescription (during the first 
few weeks), and a number of other features. Therefore, 
ECG measurements were performed in mice before 
and after the ligation of the coronary heart artery and 
coagulation in order to obtain an experimental myo-
cardial infarction. Prior to ECG recording, a mouse was 
subjected to injection narcosis using a zoletil/xylazine 
solution (40–50 mg zoletil (tiletamine + zolazepam) per 
1 kg of body weight and 15–20 mg xylazine per 1 kg of 
body weight). Then, the mouse was put in a supine po-
sition on a heated surgical table and connected to three 
electrodes: one on the left foreleg, one on the right 
foreleg, and one on the right hind leg (Fig. 2). The ECG 
was recorded on a PowerLabSupport apparatus (ECG 
Analysis Module) (ADINSTRUMENTS, Australia). The 
value of electrocardiographic waves, their duration and 
intervals were defined in accordance with the param-
eters proposed in the ECG Analysis software. The ex-
citation and repolarisation width was 100 ms (Pre-P 
was 10 ms, PR was 50 mc, and RT was 40 ms). The ECG 
was recorded prior to the surgery, 5–10 min after the 
surgery, and on the 3rd, 10th, and the 30th days after 
the surgery.
Morphological Examination
A morphological examination was performed in 32 
mouse hearts: in 21 hearts, myocardial infarction was 
simulated by ligating the left coronary artery; and 
in 11 hearts, by electrocoagulation of a myocardial 
site.  After their removal, all organs were placed into 
10% neutral formalin for 1 day, with the purpose of 
fixation. According to the macroscopic examination, 
the hearts had rather similar sizes and weights: the 
average weight of a mouse heart was 4 g, and the 
average size was 1.6 × 0.9 × 0.7 cm. In 11 cases, the 
necrosis was induced by controlled electro-coagula-
tion; a spot trace from the electrode was detected on 
the epicardium of the left ventricle during macro -
scopic examination.
For histological examination, each heart was cut into 
two pieces along the interventricular and interatrial 
septa. These pieces were subsequently held in formalin 
at room temperature for 24 h with the purpose of fur-
ther fixation.  The pieces were then washed with run-
ning water for 1–2 h. The washed pieces dehydrated at 
room temperature using several portions of solutions 
with increasing concentrations: once with 70.96 etha-
nol and twice with 100% ethanol (for 2 h). The pieces 
were then prepared to be embedded in paraffin in 
accordance with the following procedure: the pieces 
were placed into an alcohol/xylene mixture (1 : 1) for 
2 h at room temperature and held in a thermostat in 
a mixture of hot paraffin and xylene (1 : 1) for 2 h at 
60°C. The pieces dehydrated and coated with paraf-
fin were placed into metal frames with the dimensions 
2 × 2 × 2 cm and embedded with a HISTOMIX paraf-
fin medium (Biovitrum, Russia). After cooling, paraffin 
blocks containing pieces of the heart in bulk were ob-
tained. Thus, for each heart, two paraffin blocks were 
obtained, each containing the right or left heart seg-
ments, and sections of the interventricular and intera-
trial septa.
The purpose of the histological examination was 
to detect the focus of myocardial necrosis, which re-
quired the performance of a series (layer-by-layer) of 
transmural histological sections with a thickness of 5 
µm each throughout the entire thickness of the car-
diac walls from each block. The sections were prepared 
using an ACCU-CUT SRM 200 rotatory microtome 
(ACCU-CUT, Japan) and placed on slides. On aver-
age, 30 histological sections were prepared from each 
block.  Paraffin was then removed from the sections by 
holding them in a xylene solution for 15 min and treat-
ing with ethanol solutions with decreasing concentra-
tions (twice with 100% ethanol (for 3 min each time), 
and twice with 96% ethanol). After the removal of par-
affin, the sections were washed with distilled water 
and stained with Mayer’s hematoxylin and eosin. The 
stained sections were covered with polystyrene and 
placed under a cover glass.
Fig. 2. Illustration of postsurgery ECG measurements.  
A mouse is placed on a heated operation table and con-
nected to the ECG apparatus by three electrodes: one 
on the left foreleg (red), one on the right foreleg (black), 
and one on the right hind leg (black). The sutured wound 
is covered with an AluSpray suspension (shown with an 
arrow).112 | ACTA NATURAE |  VOL. 3  № 1 (8)  2011
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RESULTS AND DISCUSSION
Results of the Surgical Stage
During the first stage of the myocardial infraction 
simulation, 16 laboratory mice were operated upon. 
The ligation of the coronary artery was performed in 
12 of them, and the controlled electro-coagulation pro-
cedure was carried out on four mice. The ECG was re-
corded on four mice. The mortality rate for this group 
was 94.5%. Further, the animals from this group were 
not included into the investigation and considered as 
a test group.
After the procedure was standardized, surgeries 
were carried out in 32 animals (the ligation of the cor-
onary artery was performed in 21; and coagulation, in 
11). Let us note the important details and peculiarities 
typical to the ligation procedure. At all stages of the 
surgery described above, it is extremely important 
to follow the topographic anatomic reference points. 
Otherwise, uncontrolled bleeding or damage to lung 
tissue could occur; this is inadmissible, since it leads 
to the death of laboratory animals. After opening 
the pericardium, the anterolateral wall of the myo-
cardium with the left coronary artery in it should be 
identified. Since the coronary artery has a small di-
ameter, its identification is complicated. The left de-
scending branch of the coronary artery is character-
ized by an opalescent white band following a short 
oblique direction relative to the main direction of the 
operation procedure. When the artery was identified, 
a synthetic suture Prolene 6/0 in an autraumatic nee-
dle was brought under it. The artery was ligated, a 
microsurgical knot was formed, and the suture ends 
were cut using microsurgical scissors.  During the li-
gation stage, it is extremely important to control the 
thickness of the tissue taken; if the needle is inserted 
too deeply, the probability of myocardial perforation 
is high; which leads to immediate death. The site the 
ligature is applied to should be determined correctly, 
since if it is applied not to the descending branch but 
to the main trunk of the left coronary artery, exten-
sive myocardial infarction incompatible with life oc-
curs. In order to determine which suture material is 
optimal for this operation, a comparative study of dif-
ferent types of suture material was performed. Syn-
thetic monofilamental nonabsorbable material dem-
onstrating no sawing effect was selected; Prolene 6/0 
suture is an example of this kind of material.
The average surgery time for this group of animals 
was 57 min (39–75 min). Post-operation lethality de-
creased to 13.6% against the 94.6% observed in surgery 
in mice from the test group. These results are in agree-
ment with the published data and in line with the task 
set.
ECG Data
In most mice with myocardium infarction simulated by 
ligating the coronary artery, rhythm disturbance, i.e. 
atrial fibrillation, was observed after the surgery. On 
the 10th day after the surgery, ECG typical for large-
focal myocardial infarction was obtained; this type of 
infarction is characterized by the disappearance of the 
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Fig. 3. ECG recorded in animals after surgery: a – ECG 
recorded prior to surgery; b – impaired heart rhythm in 
5–10 minutes after ligation of the coronary artery; c – 
development of a large-focal infarction 10 days after the 
ligation of the coronary artery; d – heart rhythm measured 
5 minutes after thermal coagulation of the coronary artery; 
e – development of surface infarction 10 days after ther-
mal coagulation; f – tachycardia developed 5–10 minutes 
after the ligation of the coronary artery; g – brachycardia 
developed on day 3 after the ligation of the coronary 
artery. The excitation and repolarization width is 100 ms.RESEARCH ARTICLES
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R wave, emergence of a broad and deep QS complex, 
and lifting of the ST segment above the isoelectric line 
(Figs. 3a–3c). The formation of a large-focal myocardial 
infarction was also observed in mice on the 3rd and 9th 
day after coagulation. In some cases, coagulation result-
ed in the formation of the surface myocardial infarction 
(Figs. 3d, 3e). In the case when the coronary artery was 
ligated, the emergence of tachycardia (pathological Q 
and a decrease in the R voltage) causing bradycardia 
against a background of myocardial infarction was re-
vealed (Figs. 3f, 3g).
Results of Histological Examination
The histological examination revealed foci of necrosis 
in 28 mice (87.5%), whereas no necrosis was observed 
in 4 mice (12.5%). The mice with no necrosis belonged 
to the group of mice in which myocardial infarction 
was simulated by ligation of the coronary artery. This 
fact can in all likelihood be attributed either to the in-
dividual characteristics of heart blood supply with a 
well-developed collateral system or to an error in the 
method. A great number of types of heart blood sup-
plies are known in humans, since the development of 
the coronary arteries varies widely. Consequently, the 
contribution of each to the blood supply of the left and 
right ventricles and atria may vary for each particular 
case, as well. In addition to the main left coronary and 
right coronary arteries, the relative weight of which is 
15% (according to Smolyannikov and Naddachina [14]), 
a number of other forms of blood supply of the heart 
exist. Therefore, it can be assumed that similar features 
of blood supply are present in the mouse heart. Thus, 
the ligation of the coronary artery might have had no 
effect on the development of myocardial infarction in 
four cases.
When myocardial infarction was simulated by li-
gation of the coronary artery, the emergence of small 
scattered foci of coagulation necrosis in cardiomyocytes 
and their disorganization and the occurrence of stromal 
edema and hemorrhage without inflammatory reac-
tion (Fig. 4a) were observed in the form of necrosis of 
individual cells. These changes manifested themselves 
in the disappearance of cross striation within the sarco-
plasm of cardiomyocytes and the emergence of apop-
tosis. The changes were found in different parts of the 
left ventricle (Fig.4b).
In the case of controlled electro-coagulation, a di-
rect coagulation necrosis of the epicardium and a layer 
of cardiomyocytes were observed in the site to which 
the electrode was applied (Fig. 4c). In deeper layers of 
the myocardium, fragmentation of muscle fibers was 
observed; a histological sign of the presence of intra-
vital fibrillation of the left ventricle and edema of the 
myocardial interstitium (Figs. 4c, 4d). The fibrillation of 
ventricles is most likely associated with the direct im-
pact of the electrode on the myocardium and with the 
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Fig. 4. Histopathology of the 
hearts in the case of infarction 
simulated in mice:  a – begin-
ning of coagulational necrosis 
and cardiomyocytes disor-
ganization, stromal edema, and 
haemorrhage; hematoxylin and 
eosin staining; magnification of 
20x; b – lack of cross striation 
within the sarcoplasm of cardio-
myocytes; apoptotic patterns; 
hematoxylin and eosin staining; 
magnification of 60x; c – necro-
sis stripe of the epicardium and 
surface cardiomyocytes oc-
curring under the impact of the 
electrode during coagulation; 
edema of the myocardial inter-
stitium; hematoxylin and eosin 
staining; magnification of 10x; 
d – fragmentation of muscle 
fibers as a result of fibrillation; 
hematoxylin and eosin staining; 
magnification of 40x.114 | ACTA NATURAE |  VOL. 3  № 1 (8)  2011
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secondary ischemia induced by the damage to the local 
coronary blood flow. These sites can undergo necrotic 
changes with time, so that the necrotic zone can ex-
pand.
It should be taken into account that from the patho-
morphological point of view, infarction is a form of 
necrosis that occurs as a result of the absolute or rela-
tive insufficiency of arterial blood circulation in organs 
that have no access to oxygen. Since in the case of elec-
tro-coagulation the necrotic changes emerge mostly 
due to the direct impact of the electrode, it is unreason-
able to consider these changes as an actual myocardial 
infarction.  Myocardial infarction is based on the coagu-
lation (dry) necrosis of cardio-myoctes occurring upon 
hypoxia and developed tissue acidosis. Coagulation 
necrosis develops in tissues with a low fluid content, a 
high concentration of proteins, and a low activity of hy-
drolytic enzymes. Another form of cell death observed 
in the investigated material is apoptosis.
Apoptosis is genetically programmed cell death 
that is normally found in various organs and tissues, 
especially in those characterized by the constant re-
newal of cells. This process is a result of the activation 
of particular genes under the action of various stimuli. 
Apoptosis removes the unneeded cells that complete 
their cycle during the following processes: embryogen-
esis, homeostatic regulation of maintenance of the cell 
population in tissues, immune protection, aging, and 
removal of cells damaged by various pathologic fac-
tors. In particular, hypoxia may cause apoptosis if oxy-
gen deficiency is not critical, whereas apparent oxygen 
starvation results in cell necrosis. Histologically, the 
nucleus undergoes the most significant changes dur-
ing apoptosis. Chromatin condensates into compact ag-
gregates of various shapes and sizes (karyopyknosis), 
which manifests itself under a light microscope as an 
irregular shape and hyperchromicity of a nucleus. A 
similar situation was observed when simulating myo-
cardial infarction by ligating the coronary artery. Fur-
ther, during apoptosis, the nucleus undergoes fragmen-
tation (karyorrhexis) and cytoplasm disintegrates into 
several linked apoptotic bodies due to the formation 
of membrane bridges. Some fragments may contain 
no nuclear material at all. Finally, apoptotic bodies are 
phagocytized by surrounding healthy cells or tissue 
macrophages. Unlike necrosis, apoptotic bodies do not 
cause any inflammatory response, since the integrity of 
the cell’s membrane persists until phagocytosis, which 
prevents the excretion of cell enzymes into surrounding 
tissues and does not result in chemotaxis for inflamma-
tory cells.
Thus, the morphological patterns of changes in 
mice in which infarction was simulated by ligating 
the left coronary artery and that in the mice with inf-
arction induced by controlled electro-coagulation are 
different. In the first group, they were characterized 
by the presence of small scattered foci of coagulation 
necrosis and foci of apoptosis in different sites of the 
left ventricle occurring due to a large area of tissues 
subjected to hypoxia. The insignificance of necrotic 
foci in the case when the coronary artery is ligated 
is most likely due to the well-developed network of 
blood supply and the absence of atherosclerotic le -
sions of arteries. In the second group of mice, local 
myocardial damage emerged mostly due to the di -
rect damage done to the tissue. According to the con-
ventional stages of myocardial infarction used in the 
morphology of this disease, the histological findings 
showing the incipient coagulation necrosis of cardio-
myocytes, the edema and the hemorrhage without in-
flammatory reaction correspond to the prescription of 
a myocardial infarction of about 4–12 h. Irreversible 
changes in the myocardium at the occurrence of criti-
cal ischemia begin even after 0.5 h; however, they can 
be observed neither macroscopically nor histologically 
at this stage and can be detected only by electron mi-
croscopy.   These changes are revealed during histo-
logical examination only after 4 h. Twelve hours after 
the occurrence of the infarction, necrotic changes in-
volving karyorrhexis in the cell intensify and the first 
leukocytes emerge. After 24 h, an apparent necrosis 
of cardiomyocytes and interstitial infiltration of neu-
trophils emerge. On the fourth day, the phagocytosis 
of dead cardiomyocytes begins, and the granulation 
tissue appears at the margins of the infarction by the 
tenth day. Two weeks after the infarction, the infarc-
tion zone is completely replaced by granulation tissue 
and collagen appears. During the next six weeks, cica-
trical tissue is formed. The changes observed in the 
first group of hearts correspond to the early stage of 
myocardial infarction.
CONCLUSIONS
The results obtained in this work allow to conclude that 
optimal anesthesia for surgery on simulating myocar-
dial infarction is injecting zoletil/xylazine narcosis with 
muscle relaxants, accompanied by mechanical venti-
lation. Choosing the proper temperature conditions 
during pre-, intra- and post-operation periods allow 
to minimize the death rate of animals associated with 
nonsurgical causes. Accurate compliance with the spec-
ified anatomo-topographic landmarks during the stage 
of thoracotomy and pericardiotomy allows to minimize 
the intra-operative hemorrhage and the probability 
of lung tissue damage. Prolene 6/0 was chosen as an 
optimal suture material for ligating the descending 
branch of the left coronary artery. According to ECG 
data and postmortem histological examination, the RESEARCH ARTICLES
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model proposed for simulating a myocardial infarction 
is adequate; however, it requires further investigation 
for the purpose of standardization, in line with interna-
tional standards. 
This work was supported by the program of the 
Ministry of Education and Science (Government 
Contract № 02.467.11.3010 and Agreement  
№ 01.168.24.004).
REFERENCES
1. Burgueño A.L., Landa M.S., Schuman M.L., Alvarez A.L., 
Carabelli J., García S.I., Pirola C.J. // Metabolism. 2007. V. 
56. № 10. P. 1439–1443. 
2. Cascio W.E., Cozzi E., Hazarika S., Devlin R.B., Henriksen 
R.A., Lust R.M., van Scott M.R., Wingard C.J. // Inhal Toxi-
col. 2007. V. 19. P. 67–73.  
Matsuzawa N., Takamura T., Kurita S., Misu H., Ota T., 
Ando H., Yokoyama M., Honda M., Zen Y., Nakanuma Y., et 
al. // Hepatology. 2007. V. 46. № 5. P. 1392–1403.
3. Cohen J.K., Cai L.Q., Zhu Y.S., La Perle K.M. // Comp. Med. 
2007. V. 57. №4. P. 370-376. 
4.  Denvir M.A., Sharif I., Anderson T., Webb D.J., Gray G.A., 
McDicken W.N. // J. Am. Soc. Echocardiogr. 2005. V. 18. № 
2. P. 155–162.
5. Lee S., Schwinger R.H., Brixius K. // Pflügers Arch. 2008. 
V. 455. № 5. P. 767–774.
6. Moura R., Tjwa M., Vandervoort P., Cludts K., Hoylaerts 
M.F. // Arterioscler. Thromb. Vasc. Biol. 2007. V. 27. № 10. 
P. 2163–2169. 
7. Nogueira B.V., Peotta V.A., Meyrelles S.S., Vasquez E.C. // 
Arch. Med. Res. 2007. V. 38. № 8. P. 816–821. 
8. Rajasingh J., Bord E., Hamada H., Lambers E., Qin G., 
Losordo D.W., Kishore R. // Vet. Res. Commun. 2007. V. 31. 
P. 35–41.  
Simpson E.R., Jones M.E. // Ernst Schering Found. Symp. 
Proc. 2006. V. 1. P. 45–67.  
Son N.H., Park T.S., Yamashita H., Yokoyama M., Hug-
gins L.A., Okajima K., Homma S., Szabolcs M.J., Huang 
L.S., Goldberg I.J. // J. Clin. Invest. 2007. V. 117. № 10. P. 
2791–2801. 
9. Tang Y., Liu W., Yu S., Wang Y., Peng Q., Xiong Z., Wang 
Y., Wei T. // Plast. Reconstr. Surg. 2007. V. 120. № 4. P. 
869–878.  
10. Wang G.S., Kearney D.L., De Biasi M., Taffet G., Cooper 
T.A. // J. Clin. Invest. 2007. V. 117. № 10. P. 2802–2811.
11. Smolyannikov A. V., Naddachina T. A.  Patologicheskaya 
anatomiya koronarnoi nedostatochnosti (Pathological 
Anatomy of Coronary Insufficiency). M.: Meditsina, 1963.